| Particulars |
|
|
|
| Company Name
| Gland Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
16.50 |
B.V. (₹) |
655.30 |
| Sales(₹ Cr.) |
4,552.09 |
NP (₹ Cr.) |
1,317.59 |
| NP Var% |
21.00 |
Div% |
2,000.00 |
| CPS(₹) |
90.60 |
EPS (₹) |
79.90 |
| Traded Value(₹ Lakhs) |
91.50 |
52 Week High |
2,391.00 |
| 52 Week Low |
1,575.00 |
Price BSE |
2,221.00 |
| Price NSE |
2,220.00 |
Market Capital (₹ Cr.) |
36,635.90 |
| P/C Ratio |
24.50 |
P/E Ratio |
27.80 |
| Price Vs.BV |
3.39 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
1,261.59 |
| NP(₹ Cr.) |
420.45 |
NP Var % |
45.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
4,347.71 |
| OPM |
34.13 |
NP |
1,102.85 |
| NP Var% |
21.02 |
EPS |
79.87 |
| PE |
27.81 |
|
|